Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-09-07

FDA Approved: CEFDINIR — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for cefdinir, updating the approved labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefdinir (cefdinir)

Snippet

SUPPL AP for CEFDINIR (CEFDINIR)